DW BUREAU / chandigarh Prof. Jagat Ram, Director PGIMER commended Covishield Vaccine Trial Team for bringing laurels to the institute. It is because of the successful trial being conducted by the team in the PGIMER, and the positive outcomes of the vaccine in terms of efficacy and immunogenicity, that has contributed to the emergency use authorization of the Covishield vaccine in India. The Covishield Vaccine Trial Team was led by Prof Madhu Guptafrom the Department of Community Medicine and School of Public Health. The team included Prof. Nusrat Shafiq from Department of Pharmacology, Prof. Mini P Singh and Dr Arnab Ghoshfrom Department of Virology, Prof Pankaj Malhotra, Prof Ashish Bhalla, Prof Vikas Suri, Dr Ritin Mohindra from the Department of Internal Medicine and Dr Tarundeep Singh from the Department of Community Medicine and School of Public Health. In all, 149 volunteers were recruited in the trial. All the participants have completed 28 days post-vaccination of the second dose, and 134 participants have completed 3 months post the first dose of the vaccine without any major side effects. The follow-up of the volunteers will be continued till 6 months after the first dose of the vaccine. (editor@dailyworld.in)